Charles C Mikel

发表

Accurate 24-h urine cystine quantification for patients on cystine-binding thiol drugs

D. Goldfarb, Amy H Ponte, Charles C Mikel, 2022, Urolithiasis.

Synthesis and enhanced photosensitization ability of a 4-carboxy-2,2′:6′,2′′-terpyridine complex of ruthenium(II)

P. Potvin, Charles C Mikel, 2002 .

Illicit drug use correlates with negative urine drug test results for prescribed hydrocodone, oxycodone, and morphine.

A. Pesce, P. Horn, M. Rosenthal, 2012, Pain physician.

Illicit drug use in the pain patient population decreases with continued drug testing.

A. Pesce, P. Horn, B. Crews, 2011, Pain physician.

Marijuana correlates with use of other illicit drugs in a pain patient population.

A. Pesce, P. Horn, B. Crews, 2010, Pain physician.

Heterobiaryl human immunodeficiency virus entry inhibitors.

D. Bolognesi, S. Fisher, M. Greenberg, 2009, Journal of medicinal chemistry.

Ru(II) complexes of polyarylated terpyridines: unexpected side-chain C-metallation and photosensitization of electron transfer

P. Potvin, Charles Mikel, Charles C Mikel, 2001 .

6-Acetylmorphine Detected in the Absence of Morphine in Pain Management Patients

A. Pesce, B. Crews, P. Friel, 2009, Therapeutic drug monitoring.

Positivity rates of drugs in patients treated for opioid dependence with buprenorphine: A comparison of oral fluid and urine using paired collections and LC-MS/MS.

M. Guevara, Charles C Mikel, R. West, 2018, Drug and alcohol dependence.

Stability of pain-related medications, metabolites, and illicit substances in urine.

A. Pesce, Cameron E West, Gary Ng, 2013, Clinica chimica acta; international journal of clinical chemistry.

Determination of illicit drug cutoff values in a pain patient population.

A. Pesce, B. Crews, M. Rosenthal, 2011, Clinica chimica acta; international journal of clinical chemistry.

An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients.

A. Pesce, B. Crews, M. Rosenthal, 2010, Pain physician.

LC-MS/MS Extends the Range of Drug Analysis in Pain Patients

A. Pesce, B. Crews, Cameron E West, 2009, Therapeutic drug monitoring.

Therapeutic monitoring of benzodiazepines in the management of pain: current limitations of point of care immunoassays suggest testing by mass spectrometry to assure accuracy and improve patient safety.

A. Pesce, M. Rosenthal, Charles Mikel, 2012, Clinica chimica acta; international journal of clinical chemistry.

Anomalous observations of hydrocodone in patients on oxycodone.

A. Pesce, B. Crews, M. Rosenthal, 2011, Clinica chimica acta; international journal of clinical chemistry.

Anomalous Observations of Codeine in Patients on Morphine

A. Pesce, B. Crews, Cameron E West, 2009, Therapeutic drug monitoring.

Differentiating medicinal from illicit use in positive methamphetamine results in a pain population.

A. Pesce, Robert West, Cameron E West, 2013, Journal of analytical toxicology.

Analytical Considerations When Monitoring Pain Medications by LC-MS/MS

A. Pesce, P. Friel, D. Masters-Moore, 2014 .

Therapeutic Monitoring of Benzodiazepines in the Population of Patients Treated for Pain: Current Limitations of In-office Immunoassays Necessitate Testing by Mass Spectrometry to Assure Accuracy

A. Pesce, M. Rosenthal, Charles C Mikel, 2011 .

Comparison of Oral Fluid and Urine Drug Testing in a Population of Those with Chronic Pain

D. Masters-Moore, Charles C Mikel, S. Latyshev, 2011 .

Comparison of clonazepam compliance by measurement of urinary concentration by immunoassay and LC-MS/MS in pain management population.

A. Pesce, B. Crews, M. Rosenthal, 2010, Pain physician.

Unstable propoxyphene metabolite excreted in human urine is detected by liquid chromatography-tandem mass spectrometry.

A. Pesce, B. Crews, Charles C Mikel, 2009, Journal of analytical toxicology.

Medication and Illicit Substance Use Analyzed Using Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS) in a Pain Population

A. Pesce, Cameron E West, J. Strickland, 2012 .

False Negative Screening Values In Patients On Pain Medications

A. Pesce, Robert West, B. Crews, 2011 .

Detection of Hydrocodone and Morphine as Metabolites in Oral Fluid by LC-MS/MS in Patients Prescribed Codeine

M. Guevara, Charles C Mikel, R. West, 2017, Therapeutic drug monitoring.

A tale of two drug testing technologies: GC-MS and LC-MS/MS.

A. Pesce, Cameron E West, Charles C Mikel, 2010, Pain physician.

Improved detection of ethyl glucuronide and ethyl sulfate in a pain management population using high-throughput LC-MS/MS.

A. Pesce, B. Crews, Cameron E West, 2010, Journal of opioid management.

Determination of medication cutoff values in a pain patient population.

A. Pesce, B. Crews, M. Rosenthal, 2018, Journal of opioid management.

Reference intervals: a novel approach to detect drug abuse in a pain patient population.

A. Pesce, P. Horn, B. Crews, 2010, Journal of opioid management.

Observations of medication compliance by measurement of urinary drug concentrations in a pain management population.

A. Pesce, B. Crews, M. Rosenthal, 2010, Journal of opioid management.

Detection of the d (dextro) and l (levo) methamphetamine enantiomers in a population of those with pain

A. Pesce, Robert West, J. Velasco, 2012 .

Differentiating medicinal from illicit use in positive methamphetamine results in a pain population.

A. Pesce, Robert West, J. Velasco, 2013, Journal of analytical toxicology.